Jama Dilbeck v. HHS - Influenza, Guillain-Barre Syndrome (“GBS”) (2023)

Jama Dilbeck filed a petition for compensation under the National Vaccine Injury Compensation Program on September 14, 2022, alleging she received an influenza vaccine on October 8, 2020, and subsequently developed Guillain-Barre Syndrome (GBS). She stated the vaccine was administered in the United States, her injury had residual effects for more than six months, and she had not received prior compensation.

Respondent, the Secretary of Health and Human Services, filed a Rule 4(c) report on August 22, 2023. In this report, Respondent conceded that Petitioner is entitled to compensation, agreeing that she met the criteria for GBS as set forth in the Vaccine Injury Table and the Qualifications and Aids to Interpretation, and that she satisfied the statutory severity requirements.

Based on Respondent's concession and the evidence, Chief Special Master Corcoran found Petitioner entitled to compensation, with the case proceeding to damages.